Your browser doesn't support javascript.
loading
Symptom Improvement Following Treatment with the Inhaled Dual Phosphodiesterase 3 and 4 Inhibitor Ensifentrine in Patients with Moderate to Severe COPD - A Detailed Analysis.
Watz, Henrik; Rickard, Kathleen; Rheault, Tara; Bengtsson, Thomas; Singh, Dave.
Affiliation
  • Watz H; Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North (ARCN), Member of the German Center for Lung Research (DZL), Grosshansdorf, Germany.
  • Rickard K; Verona Pharma Plc, Raleigh, NC, USA.
  • Rheault T; Verona Pharma Plc, Raleigh, NC, USA.
  • Bengtsson T; StatMind AB, Lund, Sweden.
  • Singh D; Medicines Evaluation Unit, University of Manchester & Manchester University NHS Foundation Trust, Manchester, UK.
Int J Chron Obstruct Pulmon Dis ; 15: 2199-2206, 2020.
Article in En | MEDLINE | ID: mdl-32982212
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidinones / Phosphoric Diester Hydrolases / Pulmonary Disease, Chronic Obstructive / Isoquinolines Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Chron Obstruct Pulmon Dis Year: 2020 Document type: Article Affiliation country: Germany
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyrimidinones / Phosphoric Diester Hydrolases / Pulmonary Disease, Chronic Obstructive / Isoquinolines Type of study: Clinical_trials / Diagnostic_studies / Prognostic_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Int J Chron Obstruct Pulmon Dis Year: 2020 Document type: Article Affiliation country: Germany